| Term |
Definition |
| A |
|
| acute |
Beginning abruptly with marked intensity or sharpness, and then subsiding after a relatively short period. |
| ALA synthase |
The first enzyme in the pathway of heme biosynthesis. |
| aminolevulinic acid (ALA) |
The first compound made in the pathway of heme biosynthesis. |
| asymptomatic carrier |
A person who carries a gene that causes a disorder, but who does not show symptoms. |
| autonomic nervous system |
Controls the smooth muscle of the internal organs and glands. |
| autosomal dominant |
Only one affected parent is needed to pass on the trait to their children. There is a 50% chance of inheritance. |
| autosomal recessive |
Both parents must carry the gene mutation for it to be passed on to their children; however, rarely will either show symptoms. There is a 25% chance having a child that is affected. |
| B |
|
| barbiturates |
Act as central nervous system depressants and are used as sedatives or hypnotics. They may precipitate acute attacks. |
| beta-carotene |
A yellow pigment that gives colour to plants such as carrots and tomatoes. It is often used as a treatment for sun-sensitive porphyria. |
| bilirubin |
Formed as hemoglobin breaks down; gives bile its yellow green colour. |
| C |
|
| carbohydrate |
Sugars and starches. Carbohydrates are made up of carbon, hydrogen, and oxygen and are a main component of many foods. |
| carrier |
A person who carries a gene that causes a disorder; they may or may not show symptoms. |
| chloroquine |
A drug used mainly to treat malaria, but also used in the treatment of PCT. |
| chromatography |
A method of separating and identifying the various components of a mixture. |
| complex carbohydrates |
Starches; these are large molecules that take longer for our bodies to break down. |
| congenital |
A condition that is present at birth, as a result of either heredity or environmental influences. |
| coproporphyrin |
A compound derived from coproporphyrinogen. Increased coproporphyrin levels in the urine may indicate Congenital Erythropoietic Porphyria. |
| coproporphyrinogen |
A compound made in the pathway of heme biosynthesis. |
| coproporphyrinogen oxidase |
An enzyme in the pathway of heme biosynthesis. |
| cutaneous |
Pertaining to the skin. |
| cytochrome P-450 |
A heme-containing protein found in the liver. |
| cytochromes |
A group of heme-containing proteins involved in cellular respiration and metabolism. |
| cytoplasm |
The jellylike substance inside a cell that surrounds its nucleus. |
| D |
|
| delta-aminolevulinic acid |
See "aminolevulinic acid". |
| DNA |
Short for deoxyribonucleic acid; DNA is the molecule that carries genetic information. |
| dominant inheritance |
Only one affected parent is needed to pass on the trait to their children. There is a 50% chance of inheritance. |
| dual porphyrias |
The condition of having more than one type of porphyria. This is rare, but possible. |
| E |
|
| endogenous |
Originating from within the body. |
| enzyme |
A protein that is produced by cells and catalyzes (promotes) chemical reactions within the body. |
| erythropoietic |
Pertaining to the production of red blood cells. |
| exogenous |
Originating outside of the body. |
| F |
|
| ferrochelatase |
The last enzyme in the pathway of heme biosynthesis. |
| free erythrocyte protoporphyrin |
Heme without iron inserted. Elevated levels may indicate Erythrpoietic Protoporphyria. |
| G |
|
| gene |
The basic unit of inheritance. It is a portion of DNA that contains instructions for making a protein. |
| gene mutation |
A permanent change in a gene that can be passed on to offspring. |
| genetic predisposition |
An inherited genetic pattern which may make you more susceptible to certain diseases or conditions. |
| genetics |
The study of heredity. |
| genotype |
To determine the genetic information contained in an individual. Usually refers to determining whether a particular mutation is present or absent. Literally, the "type of gene" present. |
| globin |
The protein portion of hemoglobin. |
| glucose |
The principal circulating sugar in the blood and main energy source in the body. Glucose is often used as a treatment for acute porphyria attacks. |
| glycine |
One of twenty amino acids. It participates in the first step of heme biosynthesis. |
| H |
|
| hematin |
A blue to blackish-brown component formed in the decomposition or breaking down of hemoglobin. |
| heme |
Heme is a porphyrin ring containing iron. Heme-containing proteins function as catalysts in many biological processes. |
| heme arginate |
A heme preparation used in the treatment of porphyria. |
| heme biosynthetic cascade |
See "heme biosynthetic pathway". |
| heme biosynthetic pathway |
Refers to the enzymatically catalyzed sequential steps in the synthesis of heme. |
| hemoglobin |
A combination of porphyrin, iron, and globin (a protein). Hemoglobin enables oxygen to be carried in the blood. |
| hemolytic anemia |
Anemia resulting from the abnormal destruction of red blood cells, as in response to certain toxic or infectious agents and in certain inherited blood disorders. |
| hepatic |
Pertaining to the liver. |
| heredity (or inheritance) |
The passing on of traits from generation to generation. |
| heterozygous |
Having two different forms (or alleles) of a particular gene. In porphyria, it is most common to have one normal allele, and one with the mutation for porphyria. |
| hirsuitism |
The excessive growth of hair. |
| homozygous |
Having two of the same forms (or alleles) of a particular gene, one from each parent. When both alleles have the mutation for porphyria, it is generally more serious. |
| hydroxymethylbilane synthase |
The third enzyme in the pathway of heme biosynthesis. |
| hypoglycemia |
Low levels of glucose in the blood. (Low blood sugar.) |
| hyponatremia |
Low levels of sodium in the blood. |
| I |
|
| isomers |
Different compounds that have the same number and type of atoms, but differing arrangements. |
| K |
|
| karyotype |
The characteristics of the set of chromosomes. A photograph of one's chromosomes can be used to check for abnormalities. |
| L |
|
| latent |
Dormant, existing as a potential. A person with latent porphyria will not experience symptoms uless they are somehow triggered. |
| M |
|
| metabolic pathway |
A series of chemical reactions within a cell that are catalyzed by enzymes. |
| metabolites |
Substances that are part of the chemical reactions within one's body. |
| mitochondria |
An organelle found within the cell that produces the energy needed for cellular metabolism. |
| mutation |
A mutation in DNA is a permanent and potentially inheritable alteration that has occurred in a gene. |
| myoglobin |
The protein that carries oxygen in muscle cells. |
| N |
|
| narcotic analgesics |
A type of painkiller that stops pain signals in the brain from being transmitted. |
| neuroendocrine system |
The system of cell that release hormones that affect the nervous system. |
| neurotoxin |
A substance that is poisonous to the nerves. |
| neurotransmission |
Signals passing from nerve cell to nerve cell through chemicals or electric impulses. |
| neurovisceral |
Referring to the nerves of the internal organs. |
| P |
|
| peripheral neuropathy |
Numbness, tingling, or pain, usually in the hands and feet, caused by damage to the peripheral nerves. |
| phlebotomy |
Blood-letting; removing blood. The common treatment for Porphyria Cutanea Tarda. |
| photodermatitis |
Inflammation of the skin caused by exposure to sunlight. |
| photodynamic therapy |
A light-activated chemical is injected, then a laser is directed at harmful cells, which activates the chemical, thereby weakening or destroying the cell. |
| photosensitivity |
Increased reactivity of skin to sunlight caused by a disorder such as porphyria. |
| phototoxicity |
See "photosensitivity". |
| porphobilinogen (PBG) |
A porphyrin precursor found in large quantities in the urine in cases of acute or congenital porphyria. |
| porphobilinogen deaminase (PGB.D) |
Another name for hydroxymethylbilane synthase. |
| porphyric |
A person who has porphyria. |
| porphyrin precursors |
Refers to 5-aminolevulinic acid and porphobilinogen. |
| porphyrin synthesis |
The production of porphyrins. |
| porphyrin synthetic pathway |
The process of producing porphyrins. |
| porphyrins |
Combine with iron to make heme; excess porphyrins are present in those with porphyria. |
| porphyrogenic |
A agent or drug that can preciptate a porphyric attack. |
| protoporphyrin |
A compound made in the pathway of heme biosynthesis. |
| protoporphyrinogen |
A compound made in the pathway of heme biosynthesis. |
| protoporphyrinogen oxidase (PPO) |
An enzyme in the pathway of heme biosynthesis; a deficiency causes Variegate Porphyria. |
| pseudoporphyria |
Has the same symptoms as PCT, but there are no inherited porphyrin abnormalities; often brought on by medications or hemodialysis. |
| pyrrole |
A ring structure found in heme. |
| Q |
|
| quiescent |
At rest; not active; not causing symptoms. |
| R |
|
| recessive inheritance |
Both parents must carry the gene mutation for it to be passed on to their children, however rarely will either show symptoms. There is a 25% chance of a child being affected. |
| RNA |
Ribonucleic acid. Involved in translating the structure of DNA into the structure of protein molecules. |
| S |
|
| serum ferritin test |
Used to test the amount of iron stored in your body. The higher the serum ferritin level, the more iron you have. |
| simple carbohydrates |
Sugars made up of one or two sugar molecules, such as milk sugar (lactose). |
| singlet oxygen |
A reactive form of oxygen that is higher in energy. |
| succinyl-coenzyme A |
A compound that participates in the first step of heme biosynthesis. |
| sulfonamides |
A sulphur-containing antibiotic. |
| symptomatology |
The study of symptoms, in order to make a diagnosis. |
| T |
|
| tetrapyrrole |
Four pyrrole rings joined together. |
| transferrin saturation |
This refers to the percentage of iron-binding sites occupied by iron on the major iron-carrier protein in blood, transferrin. |
| U |
|
| uroporphyrin |
A compound derived form uroporphyrinogen. Increased uroporphyrin levels in the urine may indicate Congenital Erythropoietic Porphyria. |
| uroporphyrinogen |
A compound made in the pathway of heme biosynthesis. |
| uroporphyrinogen synthase |
A deficiency of this enzyme causes Congenital Erythropoietic Porphyria. |
| uroporphyrinogen decarboxylase (URO.D) |
An enzyme required in the process of making heme; a deficiency causes Porphyria Cutanea Tarda. |
| ultraviolet (UV) rays |
Invisible wavelengths of light that are harmful to the skin. |
| V |
|
| variegate |
To change the appearance of, or to give variety to. Variegate porphyria has symptoms similar to those of AIP but also to those of a classic photosensitive skin disorder. |
| W |
|
| Watson-Schwartz test |
A qualitative screening test for the diagnosis of AIP, based on the presence of porphobilinogen or urobilinogen in the urine. It is now considered obsolete. |